Needham & Company Reiterates a 'Buy' on Synopsys (SNPS); Strong 2Q Suggest EDA Remains Healthy

Go back to Needham & Company Reiterates a 'Buy' on Synopsys (SNPS); Strong 2Q Suggest EDA Remains Healthy